MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Medical Imaging (Image Guided Surgery & Intraoperative Surgical Navigation, Planning, Training) Companies
HistoSonics*
Organization & Developments: Histonics
Parents
HistoSonics*
Children
*Company received FDA clearance in October 2023 for its Edison histotripsy system for liver-tumor treatments.
*Company’s clinical studies show it’s 95.5% effective at treating tumors, with a complication rate of 6.8%
*EDISON SYSTEM
*Histotripsy uses focused ultrasound waves to mechanically liquify cancerous tissue
*Medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors at sub-cellular levels.
*Pioneered a groundbreaking way to treat tumors noninvasively: histotripsy
*Therapy costs $17,500 on average and is covered by Medicare.
2022: J&J leads $85M funding for HistoSonics' tumor-blasting ultrasound amid FDA review
2024: HistoSonics Lands V.A. Contract for Histotripsy Systems
2024: Meet Edison: Non-invasive tumor destruction_ histosonics
2026: HistoSonics closes new financing with value reaching $3.75B
Jumps
Finance & Acquisitions: Histonics
Key People: Histonics